Farjah Algahtani: Joining the Global Conversation at ISTH 2026
Farjah Algahtani, Director of Epidemiology and Public Health Research at King Saud University, Professor Of Hematology, shared a post on LinkedIn:
“Excited to be at ISTH 2026 in Paris!
Honored to join colleagues, researchers, and healthcare professionals from around the world at the 34th Congress of the International Society on Thrombosis and Haemostasis (ISTH) in Paris.
The congress brings together more than 6,000 experts to share the latest advances in thrombosis, hemostasis, vascular biology, and patient care.
As someone passionate about clinical research and public health, I look forward to engaging in discussions that bridge scientific innovation with real-world practice.
From emerging therapies and evidence-based medicine to global collaboration, meetings like ISTH remind us that advancing patient outcomes requires not only groundbreaking science but also strong partnerships across disciplines and countries.
These conversations have the power to shape future research, improve healthcare delivery, and ultimately enhance the lives of patients affected by thrombotic and bleeding disorders.
Looking forward to connecting with colleagues, exchanging ideas, and contributing to meaningful collaborations throughout the congress.”
Stay updated with Hemostasis Today.
-
Jul 1, 2026, 14:04Sinju Thomas: Strengthening Apheresis Excellence Through Shared Learning
-
Jul 1, 2026, 14:02Nikola Pantic: Advances in Diagnosis and Treatment of Hematological Diseases
-
Jul 1, 2026, 13:55Omar Adwan: The Diagnostic Value of Schistocytes in Hemolytic Disorders
-
Jul 1, 2026, 13:47Mostafa Faisal: Advancing Care in β-Thalassemia With Luspatercept
-
Jul 1, 2026, 13:40Tran-Hai-Yen Nguyen: Connecting with the Global Blood Transfusion Community at ISBT 2026
-
Jul 1, 2026, 12:14Ney Carter Borges: Simplifying Blood Pressure Control After Intracerebral Hemorrhage
-
Jul 1, 2026, 12:11Ifeanyichukwu Ifechidere: DOAC Monitoring – What To Order, When, And Why
-
Jul 1, 2026, 12:01Nathan Connell: Tranexamic Acid – Small Intervention, Big Impact
-
Jul 1, 2026, 08:48R.R. Baliga: The New JACC/ACC 2026 Statement Reinforces That DOAC Therapy Is Never One Size Fits All